Changes in the use of direct acting antiviral (s)(DAA) in the treatment of chronic hepatitis C (CHC) patients in clinical practice. HERACLIS: a Hellenic multicenter real-life cohort clinical study

Citation:

Papatheodoridis GV, Koskinas J, Goulis I, Sinakos E, Dalekos G, Kapatais A, Oikonomopoulou M, Vlachogiannakos J, Elefsiniotis IS, Deutsch M, et al. Changes in the use of direct acting antiviral (s)(DAA) in the treatment of chronic hepatitis C (CHC) patients in clinical practice. HERACLIS: a Hellenic multicenter real-life cohort clinical study. In: Hepatology. Vol. 66. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2017. pp. 603A–604A. Copy at http://www.tinyurl.com/ynt6baej